DINESH

Hikal Ltd

219 ▼ -1.09% 01-Jul-2026
Sell
Upside: -54.3%
Horizon: 2 Years

Stock Snapshot

Current Price
219
1 Year Target Price
56
2 Year Target Price
46
52 Week High / Low
351 / 147
20 Day Return
+14.1%
Market Cap (Cr.)
2,734
Current PE
75.5
P/BV Ratio
2.3
Dividend Yield
0.4%
Industry PE
36.1

Price Performance

Recommendation Rationale

Basis of our Recommendation

AI Generated Summary - Coming Soon!

👍 Why We Like This Stock

Things To Watch Out For

Key Parameters

Balance Sheet Strength
Weak Cash Conversion
Market Share Trend
Stable
Industry Lifecycle
Expanding
Analyst Coverage
No Coverage
Dividend History
Consistent
FII Holdings
Reducing

Financial Snapshot

Actuals Forecast
FY24 FY25 FY26 FY27 FY28
Revenue (Cr.) 1,785 1,860 1,713 1,583 1,532
Profit Before Tax (Cr.) 95 124 7 12 10
PBT Margin 5.3% 6.7% 0.4% 0.8% 0.7%
Net Profit (Cr.) 68 94 33 9 8
EPS 5.5 7.6 2.7 0.7 0.6

Company Overview

Show Company Profile

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. In addition, it offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. Further, the company provides anti-convulsant, anti-inflammatory, analgesic, Anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, Anti-viral, anti-hypertensive, and Haemorheologic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. It operates in India, the United States, Canada, Europe, South East Asia, and internationally. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.